Studien (nach Erscheinungsdatum sortiert)

Hengartner, M. P. (2022). Evidence-biased antidepressant prescription: overmedicalisation, flawed research, and conflicts of interest. Springer Nature. 

Horowitz, M., & Wilcock, M. (2022). Newer generation antidepressants and withdrawal effects: reconsidering the role of antidepressants and helping patients to stop. Drug and Therapeutics Bulletin, 60(1), 7-12. 

Brown, M. Lewis, S. (2021). The Patient Voice: Antidepressant Withdrawal, Medically Unexplained Symptoms, and Functional Neurological Disorders. Journal of Critical Psychology, Counselling, and Psychotherapy, 20 (4), 14-20.

Hengartner, M. P., & Plöderl, M. (2021). Prophylactic effects or withdrawal reactions? An analysis of time-to-event data from antidepressant relapse prevention trials submitted to the FDA. Therapeutic Advances in Psychopharmacology, 11, 20451253211032051.

Massabki, I., & Abi-Jaoude, E. (2021). Selective serotonin reuptake inhibitor ‘discontinuation syndrome’or withdrawal. The British Journal of Psychiatry, 218(3), 168-171.

White, E., Read, J., & Julo, S. (2021). The role of Facebook groups in the management and raising of awareness of antidepressant withdrawal: is social media filling the void left by health services?. Therapeutic advances in psychopharmacology, 11, 2045125320981174.

Cosci, F., & Chouinard, G. (2020). Acute and persistent withdrawal syndromes following discontinuation of psychotropic medications. Psychotherapy and Psychosomatics, 1-24.

Fava, G. A. (2020). May antidepressant drugs worsen the conditions they are supposed to treat? The clinical foundations of the oppositional model of tolerance. Therapeutic Advances in Psychopharmacology, 10, 2045125320970325.

Groot, P. C., & van Os, J. (2020). How user knowledge of psychotropic drug withdrawal resulted in the development of person-specific tapering medication. Therapeutic Advances in Psychopharmacology.

Guy, A., Brown, M., Lewis, S., & Horowitz, M. (2020). The ‘patient voice’: patients who experience antidepressant withdrawal symptoms are often dismissed, or misdiagnosed with relapse, or a new medical condition. Therapeutic Advances in Psychopharmacology, 10, 2045125320967183.

Hengartner MP, Schulthess L, Sorensen A, & Framer A. (2020). Protracted withdrawal syndrome after stopping antidepressants: a descriptive quantitative analysis of consumer narratives from a large internet forum. Ther Adv Psychopharmacol, 10, 1-13.

Hengartner, M. P., Davies, J., & Read, J. (2020). Antidepressant withdrawal–the tide is finally turning. Epidemiology and Psychiatric Sciences, 29.

Hengartner, M. P., Jakobsen, J. C., Sørensen, A., & Plöderl, M. (2020). Efficacy of new-generation antidepressants assessed with the Montgomery-Asberg Depression Rating Scale, the gold standard clinician rating scale: A meta-analysis of randomised placebo-controlled trials. PloS one, 15(2), e0229381.

Kulkarni, H., Kulkarni, S., & Saiyad, M. (2020). Severe antidepressant discontinuation syndrome for fluoxetine. Annals of Indian Psychiatry, 4(1), 98.

Davies, J., & Read, J. (2019). A systematic review into the incidence, severity and duration of antidepressant withdrawal effects: Are guidelines evidence-based?. Addictive behaviors, 97, 111-121.

Davies, J., Read, J., Hengartner, M. P., Cosci, F., Fava, G., Chouinard, G., ... & Offidani, E. (2019). Clinical guidelines on antidepressant withdrawal urgently need updating. Bmj, 365


Fava, G. A., & Cosci, F. (2019). Understanding and managing withdrawal syndromes after discontinuation of antidepressant drugs. The Journal of clinical psychiatry, 80 (6), 0-0. 

Fava, G. A., & Cosci, F. (2019). Addressing clinical challenges of antidepressant discontinuation. American Journal of Psychiatry, 176(6), 487-488. 

Horowitz, M. A., & Taylor, D. (2019). Tapering of SSRI treatment to mitigate withdrawal symptoms. The Lancet Psychiatry, 6(6), 538-54. 


Iacobucci, G. (2019). NICE updates antidepressant guidelines to reflect severity and length of withdrawal symptoms. BMJ: British Medical Journal (Online), 367

Récalt, A. M., & Cohen, D. (2019). Withdrawal confounding in randomized controlled trials of antipsychotic, antidepressant, and stimulant drugs, 2000–2017. Psychotherapy and psychosomatics, 88(2), 105-113.

Fava, G. A., Benasi, G., Lucente, M., Offidani, E., Cosci, F., & Guidi, J. (2018). Withdrawal symptoms after serotonin-noradrenaline reuptake inhibitor discontinuation: systematic review. Psychotherapy and Psychosomatics, 87(4), 195-203. 

Stockmann, T., Odegbaro, D., Timimi, S., & Moncrieff, J. (2018). SSRI and SNRI withdrawal symptoms reported on an internet forum. International Journal of Risk & Safety in Medicine, 29(3-4), 175-180.

Carvalho, A. F., Sharma, M. S., Brunoni, A. R., Vieta, E., & Fava, G. A. (2016). The safety, tolerability and risks associated with the use of newer generation antidepressant drugs: a critical review of the literature. Psychotherapy and psychosomatics, 85(5), 270-288. 

Chouinard, G., & Chouinard, V. A. (2015). New classification of selective serotonin reuptake inhibitor withdrawal. Psychotherapy and Psychosomatics, 84(2), 63-71. 

Fava, G. A., Gatti, A., Belaise, C., Guidi, J., & Offidani, E. (2015). Withdrawal symptoms after selective serotonin reuptake inhibitor discontinuation: a systematic review. Psychotherapy and psychosomatics, 84(2), 72-81. 

Belaise, C., Gatti, A., Chouinard, V. A., & Chouinard, G. (2012). Patient online report of selective serotonin reuptake inhibitor-induced persistent postwithdrawal anxiety and mood disorders. Psychotherapy and psychosomatics, 81(6), 386-388.

Nielsen, M., Hansen, E. H., & Gøtzsche, P. C. (2012). What is the difference between dependence and withdrawal reactions? A comparison of benzodiazepines and selective serotonin re‐uptake inhibitors. Addiction, 107(5), 900-908. 


Moncrieff, J. (2006). Why is it so difficult to stop psychiatric drug treatment?: It may be nothing to do with the original problem. Medical Hypotheses, 67(3), 517-523. 

Warner, C. H., Bobo, W., Warner, C. M., Reid, S., & Rachal, J. (2006). Antidepressant discontinuation syndrome. American family physician, 74(3), 449-456.

Studien zu Kindling-Effekten bzw.nervous system destabilization:

Framer, A. (2021). What I have learnt from helping thousands of people taper off antidepressants and other psychotropic medications. Therapeutic Advances in Psychopharmacology, 11, 2045125321991274.  

Kraus, J. E. (2000). Sensitization phenomena in psychiatric illness: lessons from the kindling model. The Journal of neuropsychiatry and clinical neurosciences, 12(3), 328-343. 

Kaymaz, N., van Os, J., Loonen, A. J., & Nolen, W. A. (2008). Evidence that patients with single versus recurrent depressive episodes are differentially sensitive to treatment discontinuation: a meta-analysis of placebo-controlled randomized trials. The Journal of clinical psychiatry, 69(9), 6813. 

Bell, I. R., Rossi 3rd, J., Gilbert, M. E., Kobal, G., Morrow, L. A., Newlin, D. B., ... & Wood, R. W. (1997). Testing the neural sensitization and kindling hypothesis for illness from low levels of environmental chemicals. Environmental Health Perspectives, 105(suppl 2), 539-547. 

Onlinequellen, Bücher, Artikel

International Institute for Psychiatric Drug Withdrawal IIPDW

How hard is it to stop antidepressants?

Stockmann, T. (2019). What it was like to stop an antidepressant. Therapeutic advances in psychopharmacology, 9, 2045125319884834.

Stopping antidepressants

Ed White (RIP)












Foren & Erfahrungsberichte


Absetzsymptomliste des Antidepressiva Forum Deutschland(adfd):